Contact
searchSearch
HMP Global
Quiz

Can early intervention with teriflunomide prevent the development of multiple sclerosis?

09/20/2023

Migraine CME Series

News

a doctor sits at a desk and takes notes while looking at a laptop
News
Teleneurological Ward Rounds Noninferior to On-Site Care in Subacute Stroke Patients
04/13/2026
Maria Mantas
Teleneurological ward rounds were found noninferior to conventional on-site ward rounds in subacute inpatient stroke care, according to prospective study findings.
Teleneurological ward rounds were found noninferior to conventional on-site ward rounds in subacute inpatient stroke care, according to prospective study findings.
Teleneurological ward rounds...
04/13/2026
Neurology
an older man wearing a mask receives a vaccination shot in his upper arm
News
High-Dose Flu Vaccine Tied to Lower Alzheimer Risk
04/09/2026
Brionna Mendoza
High-dose influenza vaccination may confer additional neuroprotective benefit beyond standard-dose formulations, according to results from a new, large retrospective cohort study published in Neurology.
High-dose influenza vaccination may confer additional neuroprotective benefit beyond standard-dose formulations, according to results from a new, large retrospective cohort study published in Neurology.
High-dose influenza vaccination...
04/09/2026
Neurology
a gloved hand holds up brain scans
News
Early vs Delayed Extubation Yields Similar Stroke Recovery
04/06/2026
Maria Mantas
According to recent findings, early extubation after thrombectomy did not improve 90-day functional independence compared with delayed extubation in patients with acute ischemic stroke.
According to recent findings, early extubation after thrombectomy did not improve 90-day functional independence compared with delayed extubation in patients with acute ischemic stroke.
According to recent findings,...
04/06/2026
Neurology
spilled bottle of white pills
News
Tavapadon Improves Parkinson Disease Motor Fluctuations in Phase 3 Trial
03/26/2026
Maria Mantas
A phase 3 clinical trial found that tavapadon, an investigational oral D1/D5 dopamine agonist, was effective as an adjunctive therapy to levodopa for motor fluctuations in Parkinson disease (PD).
A phase 3 clinical trial found that tavapadon, an investigational oral D1/D5 dopamine agonist, was effective as an adjunctive therapy to levodopa for motor fluctuations in Parkinson disease (PD).
A phase 3 clinical trial found...
03/26/2026
Neurology
a woman holds another person's hand for support
News
Suicidality at Epilepsy Diagnosis Predicts Future Drug Resistance Risk
03/16/2026
Maria Mantas
A prospective cohort study found that suicidality at the time of focal epilepsy diagnosis was linked to a more than twofold increased risk of future antiseizure medication (ASM) treatment resistance.
A prospective cohort study found that suicidality at the time of focal epilepsy diagnosis was linked to a more than twofold increased risk of future antiseizure medication (ASM) treatment resistance.
A prospective cohort study found...
03/16/2026
Neurology
A woman lies on the couch holding an ice pack to her head
News
Migraine Nearly Doubles Depression and Anxiety Risk in Cohort Study
03/10/2026
Brionna Mendoza
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2...
03/10/2026
Psych Congress Network
A nurse and a doctor review information on a computer in a lab clinical study research trial
News
Fenebrutinib for Multiple Sclerosis Returns Significant Phase III Results
03/04/2026
Brionna Mendoza
The pivotal Phase III FENhance 1 trial of fenebrutinib met its primary endpoint in relapsing multiple sclerosis (RMS), demonstrating statistically significant and clinically meaningful reductions in relapse activity.
The pivotal Phase III FENhance 1 trial of fenebrutinib met its primary endpoint in relapsing multiple sclerosis (RMS), demonstrating statistically significant and clinically meaningful reductions in relapse activity.
The pivotal Phase III FENhance 1...
03/04/2026
Neurology
a bowl of fruits and vegetables indicates brain health
News
DASH Diet Linked to Lower Subjective Cognitive Decline Risk
03/02/2026
Maria Mantas
In a prospective cohort of 159,347 US adults, higher adherence to 6 healthy dietary patterns was associated with lower risk of subjective cognitive decline (SCD).
In a prospective cohort of 159,347 US adults, higher adherence to 6 healthy dietary patterns was associated with lower risk of subjective cognitive decline (SCD).
In a prospective cohort of...
03/02/2026
Neurology
a colorful illustration of the brain
News
Five-Year Ublituximab Efficacy Sustained in Relapsing MS Trial
02/23/2026
Maria Mantas
Ublituximab provided sustained reductions in disease activity and disability progression over 5 years in adults with relapsing multiple sclerosis (RMS), according to open-label extension study findings.
Ublituximab provided sustained reductions in disease activity and disability progression over 5 years in adults with relapsing multiple sclerosis (RMS), according to open-label extension study findings.
Ublituximab provided sustained...
02/23/2026
Neurology
a row of pill bottles on a shelf
News
Cenobamate Shows Superior Effectiveness in Drug-Resistant Focal Epilepsy
02/17/2026
Maria Mantas
A large, pooled analysis found that cenobamate outperformed brivaracetam, lacosamide, and perampanel as adjunctive therapy in adults with drug-resistant focal epilepsy.
A large, pooled analysis found that cenobamate outperformed brivaracetam, lacosamide, and perampanel as adjunctive therapy in adults with drug-resistant focal epilepsy.
A large, pooled analysis found...
02/17/2026
Neurology

Alzheimer's Disease CME Series

Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use